Seer Secures European Patent Victory Amid U.S. ITC Probe of Nanomics
Event summary
- Seer's European patent EP4056263 upheld by EPO on June 25, 2026 after opposition proceedings.
- US ITC opens investigation into Nanomics' Proteonano kits and workstations on June 29, 2026.
- Seer holds over 250 patent applications worldwide, with 84 issued patents protecting its core technology.
The big picture
Seer's dual victories in Europe and the U.S. reinforce its position as a leader in proteomics technology, particularly in nanoparticle-based protein enrichment. The ITC investigation against Nanomics highlights growing competition in the space, while Seer's robust patent portfolio suggests it is well-positioned to defend its market share. The outcome of these legal battles could shape the future landscape of proteomic research tools.
What we're watching
- IP Enforcement Pace
- How quickly Seer can secure favorable rulings in both European and U.S. patent disputes.
- Market Impact
- Whether the ITC investigation will create barriers to Nanomics' U.S. operations.
- Technological Leadership
- The extent to which Seer can maintain its competitive edge through patent protection.
Related topics